{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:49:49Z","timestamp":1789008589074,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1016\/j.yebeh.2003.07.008","type":"journal-article","created":{"date-parts":[[2003,9,22]],"date-time":"2003-09-22T19:26:20Z","timestamp":1064258780000},"page":"537-547","source":"Crossref","is-referenced-by-count":87,"title":["Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases"],"prefix":"10.1016","volume":"4","author":[{"given":"Vera","family":"Dinkelacker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dietl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Widman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Lengler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian E","family":"Elger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2003.07.008_BIB1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(95)00436-O","article-title":"The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes","volume":"286","author":"Noyer","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yebeh.2003.07.008_BIB2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(98)00410-5","article-title":"Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy","volume":"353","author":"Klitgaard","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 4","key":"10.1016\/j.yebeh.2003.07.008_BIB3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1528-1157.2001.0420s4044.x","article-title":"The place of levetiracetam in the treatment of epilepsy","volume":"42","author":"Leppik","year":"2001","journal-title":"Epilepsia"},{"issue":"Suppl. 4","key":"10.1016\/j.yebeh.2003.07.008_BIB4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1528-1157.2001.0420s4031.x","article-title":"Efficacy of levetiracetam: a review of three pivotal clinical trials","volume":"42","author":"Privitera","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB5","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000mg\/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group","volume":"41","author":"Ben Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/seiz.2000.0380","article-title":"A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000mg daily and 4000mg daily, without titration in patients with refractory epilepsy","volume":"9","author":"Betts","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0920-1211(00)00158-3","article-title":"Efficacy and tolerability of 1000\u20134000mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy","volume":"42","author":"Grant","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB9","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1528-1157.2000.tb00323.x","article-title":"Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures","volume":"41","author":"Shorvon","year":"2000","journal-title":"Epilepsia"},{"issue":"Suppl. 4","key":"10.1016\/j.yebeh.2003.07.008_BIB10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1528-1157.2001.00008.x","article-title":"Safety profile of levetiracetam","volume":"42","author":"Harden","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0920-1211(01)00296-0","article-title":"A systematic review of the safety profile of levetiracetam: a new antiepileptic drug","volume":"47","author":"French","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.yebeh.2003.07.008_BIB12","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1046\/j.1528-1157.2001.32101.x","article-title":"Levetiracetam psychosis in children with epilepsy","volume":"42","author":"Kossoff","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00004703-200208000-00006","article-title":"Levetiracetam in autistic children: an open-label study","volume":"23","author":"Rugino","year":"2002","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.yebeh.2003.07.008_BIB14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1176\/appi.ajp.159.1.148","article-title":"Levetiracetam for acute mania","volume":"159","author":"Goldberg","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB15","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1528-1157.2000.tb00255.x","article-title":"Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group","volume":"41","author":"Cramer","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1059-1311(02)00251-0","article-title":"Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy","volume":"12","author":"Ben-Menachem","year":"2003","journal-title":"Seizure"},{"issue":"Suppl. 7","key":"10.1016\/j.yebeh.2003.07.008_BIB17","first-page":"259","article-title":"Possible association of behavioral disturbances with levetiracetam: Report of a case series","volume":"42","author":"Rickles","year":"2001","journal-title":"Epilepsia"},{"issue":"Suppl. 7","key":"10.1016\/j.yebeh.2003.07.008_BIB18","first-page":"7:299","article-title":"Behavioral changes associated with levetiracetam use in patients with epilepsy","volume":"42","author":"Asconap\u00e9","year":"2001","journal-title":"Epilepsia"},{"issue":"Suppl. 7","key":"10.1016\/j.yebeh.2003.07.008_BIB19","first-page":"58","article-title":"Behavioral and emotional effects of levetiracetam in children with intractable epilepsy","volume":"43","author":"Gustafson","year":"2002","journal-title":"Epilepsia"},{"issue":"Suppl. 7","key":"10.1016\/j.yebeh.2003.07.008_BIB20","first-page":"187","article-title":"Behavioral side effects of levetiracetam","volume":"43","author":"Gates","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB21","first-page":"341","article-title":"Psychobiology of ictal aggression","volume":"55","author":"Treiman","year":"1991","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.yebeh.2003.07.008_BIB22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/ebeh.2000.0061","article-title":"Aggression and violence in patients with epilepsy","volume":"1","author":"Marsh","year":"2000","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.yebeh.2003.07.008_BIB23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1528-1157.1999.tb01996.x","article-title":"Violence and epilepsy: a close relation between violence and postictal psychosis","volume":"40","author":"Kanemoto","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00002018-200124070-00004","article-title":"Behavioral effects of the new anticonvulsants","volume":"24","author":"Besag","year":"2001","journal-title":"Drug Saf."},{"key":"10.1016\/j.yebeh.2003.07.008_BIB25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.1973.01750320044007","article-title":"Psychomotor epilepsy and aggressive behavior","volume":"28","author":"Rodin","year":"1973","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB26","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1176\/ps.47.7.762","article-title":"Epilepsy, aggression, and criminal responsibility","volume":"47","author":"Borum","year":"1996","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.yebeh.2003.07.008_BIB27","series-title":"Neuropsychiatry","first-page":"523","article-title":"Neuropsychiatry of aggression","author":"Saver","year":"1996"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0010-440X(97)90031-6","article-title":"Violence in psychiatric patients: the role of psychosis, frontal lobe impairment, and ward turmoil","volume":"38","author":"Krakowski","year":"1997","journal-title":"Compr. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2003.07.008_BIB29","first-page":"1","article-title":"Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability","volume":"42","author":"Alvarez","year":"1998","journal-title":"J. Intellect. Disabil. Res."},{"issue":"Pt. 2","key":"10.1016\/j.yebeh.2003.07.008_BIB30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/brain\/123.2.234","article-title":"Affective aggression in patients with temporal lobe epilepsy: a quantitative MRI study of the amygdala","volume":"123","author":"van Elst","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jnnp.68.2.162","article-title":"Reduction of frontal neocortical grey matter associated with affective aggression in patients with temporal lobe epilepsy: an objective voxel by voxel analysis of automatically segmented MRI","volume":"68","author":"Woermann","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1528-1157.1996.tb00598.x","article-title":"Gabapentin associated with aggressive behavior in pediatric patients with seizures","volume":"37","author":"Tallian","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1528-1157.1998.tb01373.x","article-title":"Aggressive behavior in intellectually challenged patients with epilepsy treated with lamotrigine","volume":"39","author":"Beran","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB34","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1176\/appi.ajp.157.7.1178","article-title":"Aggression in dementia with lamotrigine treatment","volume":"157","author":"Devarajan","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB35","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1528-1157.2000.tb00282.x","article-title":"Topiramate in refractory epilepsy: a prospective observational study","volume":"41","author":"Stephen","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/1059-1311(92)90018-V","article-title":"Vigabatrin in adults with poorly-controlled epilepsy and learning disabilities","volume":"1","author":"Armour","year":"1992","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0891-4222(92)90012-U","article-title":"A case of phenobarbital exacerbation of a preexisting maladaptive behavior partially suppressed by chlorpromazine and misinterpreted as chlorpromazine efficacy","volume":"13","author":"Hanzel","year":"1992","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.yebeh.2003.07.008_BIB38","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00002826-199408000-00004","article-title":"Aggression in children treated with clobazam for epilepsy","volume":"17","author":"Sheth","year":"1994","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.yebeh.2003.07.008_BIB39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1176\/appi.ajgp.8.3.221","article-title":"A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias","volume":"8","author":"Hawkins","year":"2000","journal-title":"Am. J. Geriatr. Psychiatry."},{"key":"10.1016\/j.yebeh.2003.07.008_BIB40","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1345\/aph.1A102","article-title":"Lamotrigine update and its use in mood disorders","volume":"36","author":"Hurley","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.yebeh.2003.07.008_BIB41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/026990599121188","article-title":"Carbamazepine in agitation and aggressive behavior following severe closed-head injury: results of an open trial","volume":"13","author":"Azouvi","year":"1999","journal-title":"Brain Inj."},{"key":"10.1016\/j.yebeh.2003.07.008_BIB42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4088\/JCP.v61n0207","article-title":"Use of sodium valproate in violent and aggressive behaviors: a critical review","volume":"61","author":"Lindenmayer","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB43","series-title":"Lectures on epilepsy","first-page":"91","article-title":"Serial EEG investigations during psychotic episodes in epileptic patients and during schizophrenic attacks","author":"Landolt","year":"1958"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archneur.1987.00520150039018","article-title":"Forced normalization: acute psychosis after seizure control in seven patients","volume":"44","author":"Pakalnis","year":"1987","journal-title":"Arch. Neurol."},{"issue":"Suppl. 10","key":"10.1016\/j.yebeh.2003.07.008_BIB45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1528-1157.1999.tb00886.x","article-title":"Forced normalization: clinical and therapeutic relevance","volume":"40","author":"Krishnamoorthy","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.07.008_BIB46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2869.2002.00301.x","article-title":"The effects of levetiracetam on objective and subjective sleep parameters in healthy volunteers and patients with partial epilepsy","volume":"11","author":"Bell","year":"2002","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.yebeh.2003.07.008_BIB47","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1365-2788.1999.00234.x","article-title":"Sleep problems and daytime challenging behaviour in a community-based sample of adults with intellectual disability","volume":"43","author":"Brylewski","year":"1999","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.yebeh.2003.07.008_BIB48","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2788.2002.00404.x","article-title":"Sleep problems and daytime problem behaviours in children with intellectual disability","volume":"46","author":"Didden","year":"2002","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.yebeh.2003.07.008_BIB49","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0022-3956(03)00041-4","article-title":"Human impulsive aggression: a sleep research perspective","volume":"37","author":"Lindberg","year":"2003","journal-title":"J. Psychiatr. Res."}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505003001902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505003001902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,24]],"date-time":"2019-02-24T00:26:16Z","timestamp":1550967976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505003001902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S1525505003001902"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2003.07.008","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}